• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Lliac artery stenting shows good long-term results

Article

Endovascular stenting as the initial treatment for patients with occluded iliac arteries has been shown to be both safe and cost-effective by more than five years of follow-up in the Dutch Iliac Stent Trial.

Endovascular stenting as the initial treatment for patients with occluded iliac arteries has been shown to be both safe and cost-effective by more than five years of follow-up in the Dutch Iliac Stent Trial.

Dr. Willemijn M. Klein and colleagues retrospectively reviewed 143 patients who underwent primary stent placement and 136 who underwent primary angioplasty followed by selective stent placement. They found no statistically significant difference between the two groups in the number of reinterventions, additional cardiovascular events, or mortality.

The real danger for these patients is cardiovascular complications leading to fatal episodes, according to a study in the August issue of Radiology. Peripheral artery disease should thus be considered a marker of potentially dangerous atherosclerotic disease elsewhere in the body, the researchers said.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.